Birdwatch Archive

Birdwatch Note

2023-09-08 10:13:54 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

福島雅典さんは政府はワクチンの重症化を防ぐといいながら、堂々とデータを出さない！と主張していますが 厚労省から研究費を受け30近い医療機関が参加した長崎大学、versusプロジェクト(https://www.tm.nagasaki-u.ac.jp/versus/about.html)がワクチンの重症や入院予防のデータを提供しており、2022年10月～23年3月の期間にも80％の入院予防効果が確認されており堂々と公表されています。 https://www.tm.nagasaki-u.ac.jp/versus/results/20230725.html オミクロン流行以降の世界中の研究のメタアナリシスでオミクロンに対してもワクチンの重症予防効果が確認されています。 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00409-1/fulltext

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1699736689428894076

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1700090074954969368
  • noteId - 1700090074954969368
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1694168034675
  • tweetId - 1699736689428894076
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 福島雅典さんは政府はワクチンの重症化を防ぐといいながら、堂々とデータを出さない！と主張していますが 厚労省から研究費を受け30近い医療機関が参加した長崎大学、versusプロジェクト(https://www.tm.nagasaki-u.ac.jp/versus/about.html)がワクチンの重症や入院予防のデータを提供しており、2022年10月～23年3月の期間にも80％の入院予防効果が確認されており堂々と公表されています。 https://www.tm.nagasaki-u.ac.jp/versus/results/20230725.html オミクロン流行以降の世界中の研究のメタアナリシスでオミクロンに対してもワクチンの重症予防効果が確認されています。 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00409-1/fulltext

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-09-08 10:13:54 UTC
(1694168034675)		 1969-12-31 23:59:59 UTC
(-1)		 2023-09-09 02:14:48 UTC
(1694225688555)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-09-08 08:00:01 -0500 Rating Details
2023-09-08 07:30:23 -0500 Rating Details
2023-09-08 07:22:02 -0500 Rating Details
2023-09-08 07:14:00 -0500 Rating Details
2023-09-08 06:49:55 -0500 Rating Details
2023-09-08 06:44:03 -0500 Rating Details
2023-09-08 06:35:37 -0500 Rating Details
2023-09-08 06:28:20 -0500 Rating Details
2023-09-08 06:15:04 -0500 Rating Details
2023-09-08 06:08:29 -0500 Rating Details
2023-09-08 05:44:06 -0500 Rating Details
2023-09-08 05:42:12 -0500 Rating Details
2023-09-08 05:37:52 -0500 Rating Details
2023-09-08 05:25:07 -0500 Rating Details
2023-09-09 14:49:39 -0500 Rating Details
2023-09-10 00:18:30 -0500 Rating Details
2023-09-12 09:57:14 -0500 Rating Details
2023-09-13 02:52:19 -0500 Rating Details
2023-09-19 09:42:13 -0500 Rating Details
2023-09-19 09:39:07 -0500 Rating Details
2023-09-19 08:25:00 -0500 Rating Details
2023-09-19 06:10:43 -0500 Rating Details
2023-09-20 06:12:44 -0500 Rating Details
2023-09-20 02:46:00 -0500 Rating Details
2023-09-21 09:12:42 -0500 Rating Details
2023-10-22 07:02:04 -0500 Rating Details
2023-10-30 18:29:49 -0500 Rating Details
2023-10-30 18:27:10 -0500 Rating Details
2023-10-30 17:59:49 -0500 Rating Details
2023-10-30 17:37:23 -0500 Rating Details
2023-10-30 16:16:18 -0500 Rating Details
2023-10-30 15:51:03 -0500 Rating Details
2023-10-30 11:21:25 -0500 Rating Details
2023-10-30 11:15:42 -0500 Rating Details
2023-10-30 21:25:11 -0500 Rating Details
2023-10-30 21:04:46 -0500 Rating Details
2023-10-30 20:35:13 -0500 Rating Details
2023-10-30 20:25:03 -0500 Rating Details
2023-10-30 21:19:43 -0500 Rating Details
2023-10-30 19:58:30 -0500 Rating Details
2023-10-30 19:57:30 -0500 Rating Details
2023-10-30 19:53:03 -0500 Rating Details
2023-10-30 19:34:47 -0500 Rating Details
2023-10-30 18:37:34 -0500 Rating Details
2023-10-30 18:11:54 -0500 Rating Details
2023-10-30 17:34:40 -0500 Rating Details
2023-10-30 17:04:26 -0500 Rating Details
2023-10-30 17:04:00 -0500 Rating Details
2023-10-30 16:35:36 -0500 Rating Details
2023-10-30 11:25:14 -0500 Rating Details
2023-10-30 10:52:25 -0500 Rating Details
2023-11-11 00:44:02 -0600 Rating Details
2023-11-13 18:23:30 -0600 Rating Details
2023-11-13 18:18:36 -0600 Rating Details
2023-11-13 18:15:29 -0600 Rating Details
2023-11-13 18:13:18 -0600 Rating Details
2023-11-13 17:59:32 -0600 Rating Details
2023-11-13 17:57:16 -0600 Rating Details
2023-11-13 17:18:40 -0600 Rating Details
2023-11-13 16:32:58 -0600 Rating Details
2023-11-13 15:37:45 -0600 Rating Details
2023-11-13 12:03:05 -0600 Rating Details
2023-11-13 11:08:08 -0600 Rating Details
2023-11-13 11:02:12 -0600 Rating Details
2023-11-13 08:50:27 -0600 Rating Details
2023-11-14 05:08:50 -0600 Rating Details
2023-11-14 04:51:47 -0600 Rating Details
2023-11-14 04:46:45 -0600 Rating Details
2023-11-13 23:26:25 -0600 Rating Details
2023-11-13 21:38:32 -0600 Rating Details
2023-11-13 21:07:26 -0600 Rating Details
2023-11-13 18:57:48 -0600 Rating Details
2023-11-13 18:36:43 -0600 Rating Details
2023-11-17 14:25:15 -0600 Rating Details
2023-11-17 18:55:32 -0600 Rating Details
2023-11-24 01:21:10 -0600 Rating Details
2023-11-24 00:40:15 -0600 Rating Details
2023-11-24 00:01:24 -0600 Rating Details
2023-11-24 00:28:29 -0600 Rating Details
2023-11-23 23:51:46 -0600 Rating Details